Английская Википедия:Cadonilimab

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Orphan Шаблон:Infobox drug Cadonilimab is a PD-1/CTLA-4 bispecific monoclonal antibody[1][2] developed to treat a variety of solid cancer types. In June 2022 it was approved in China "for use in patients with relapsed or metastatic cervical cancer (r/mCC) who have progressed on or after platinum-based chemotherapy".[3]

References

Шаблон:Reflist